Physician profile
Tyler Iodence
NPI 1639732449
$26,186.38
in general payments reported to CMS, 2019-2025
11 companies · $3,816 in 2025
The $3,816 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $22K · 2025: $3,816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Travel and Lodging: $3,753 · Food and Beverage: $2,434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Travel and Lodging | $3,752.53 |
| Food and Beverage | $2,433.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $22,110.33 | 2024-2025 | |
| Stryker Corporation | $2,667.27 | 2024-2025 | Makoplasty, Tritanium, Variax |
| Depuy Synthes Sales INC. | $462.80 | 2024 | |
| Medical Device Business Services, INC. | $238.50 | 2025 | Velys, Actis, Attune |
| Fortis Surgical, LLC | $227.70 | 2024 | |
| Smoky Mountain Surgical LLC | $157.09 | 2025 | |
| Vericel Corporation | $124.62 | 2024-2025 | Maci |
| Exactech, INC. | $97.11 | 2025 | |
| Biocomposites INC | $66.53 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $17.25 | 2025 | Exparel |
| Convatec INC. | $17.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Iodence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.